SCHEMBL31453

SCHEMBL31453

CCCc1ccc(CC(=O)O)cc1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.77
HPGD P15428 2/20 0.77
HSD17B10 Q99714 2/20 0.77
L3MBTL1 Q9Y468 1/20 0.58
CA2 P00918 1/20 0.58
CAMK2A Q9UQM7 1/20 0.58
AKR1B1 P15121 1/20 0.56
ABCC4 O15439 1/20 0.54
LMNA P02545 1/20 0.54
GAA P10253 1/20 0.54
TSHR P16473 1/20 0.54
PTGS1 P23219 1/20 0.54
HTT P42858 1/20 0.54
PLK1 P53350 1/20 0.52
THRB P10828 2/20 0.50
KLKB1 P03952 1/20 0.50
CTSB P07858 1/20 0.50
KDM4E B2RXH2 1/20 0.48
MAPT P10636 1/20 0.48
FFAR1 O14842 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2533472 0.98 ALDH1A1 (0.74) ALDH1A1HPGDHSD17B10L3MBTL1CA2
SCHEMBL1445637 0.87 ALDH1A1 (1.00) ALDH1A1HPGDHSD17B10L3MBTL1CA2
SCHEMBL2996429 0.85 CA2 (0.68) ALDH1A1HPGDHSD17B10CA2CAMK2A
SCHEMBL846163 0.85 ALDH1A1 (1.00) ALDH1A1HPGDHSD17B10LMNAPTGS1
Hydrochloric Acid SCHEMBL2529595 0.85 ALDH1A1 (0.96) ALDH1A1HPGDHSD17B10CA2CAMK2A
SCHEMBL8337401 0.84 ALDH1A1 (0.96) ALDH1A1HPGDHSD17B10LMNAPTGS1
SCHEMBL9522105 0.84 ALDH1A1 (0.96) ALDH1A1HPGDHSD17B10LMNAPTGS1
SCHEMBL2674656 0.84 ALDH1A1 (0.96) ALDH1A1HPGDHSD17B10LMNAPTGS1
SCHEMBL6801680 0.84 ALDH1A1 (0.96) ALDH1A1HPGDHSD17B10LMNAPTGS1
SCHEMBL9523042 0.84 ALDH1A1 (0.96) ALDH1A1HPGDHSD17B10LMNAPTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1202191-A Foamable polyester compositions having low levels of unreacted branching agent EASTMAN CHEM CO (US) 1998-12-16 CN claimed
CN-120118077-A Compound and application thereof 润尔眼科药物(广州)有限公司 2025-06-10 CN disclosed
WO-2023160582-A1 THIAZOLAMINE MBL INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF 四川大学 2023-08-31 WO disclosed
CN-114790136-A Preparation method and application of active trivalent organic chromium compound 中国石油天然气股份有限公司 2022-07-26 CN disclosed
US-9908848-B2 Amide derivatives of lactam based N-acylethanolamine acid amidase (NAAA) inhibitors THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2018-03-06 US disclosed
EP-2661428-B1 QUINOXALINES AND AZA-QUINOXALINES AS CRTH2 RECEPTOR MODULATORS MERCK SHARP & DOHME (US) 2017-06-07 EP disclosed
CN-103228621-B Labeling reagent, and method for sequencing and quantifying polypeptide and protein using same 浦项工科大学校产学协力团 2016-06-15 CN disclosed
CN-102869489-B Laminated vessel, the laminated vessel manufacture method of mould and laminated vessel MITSUBISHI GAS CHEMICAL CO.,INC. (JP) 2016-05-25 CN disclosed
US-9290453-B2 Quinolines and aza-quinolines as CRTH2 receptor modulators MERCK SHARP & DOHME CORP. (US) 2016-03-22 US disclosed
US-20160068483-A1 AMIDE DERIVATIVES OF LACTAM BASED N-ACYLETHANOLAMINE ACID AMIDASE (NAAA) INHIBITORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2016-03-10 US disclosed
CN-1327458-A Method for producing polyester block copolymer, polyester block copolymer composition, and method for producing same DAICEL CHEM (JP) 2001-12-19 CN disclosed
CN-1206027-A Thermoplastic resin composition DAICEL CHEM (JP) 1999-01-27 CN disclosed
CN-1197446-A Inorganic-organic composite foam and process for the prodn. thereof SANYO CHEMICAL IND LTD (JP) 1998-10-28 CN disclosed
CN-1180689-A Method for preparation of recycled polyols and method for manufacturing polyurethane foams therefrom SAMSUNG ELECTRONICS CO LTD (KR) 1998-05-06 CN disclosed
CN-1118170-A Resin composition capable of exhibiting high melt viscoelasticity, aromatic polyester resin foam produced therefrom, and process for producing the foam KANEGAFUCHI CHEMICAL IND (JP) 1996-03-06 CN disclosed
EP-0252961-B1 HETEROCYCLIC COMPOUNDS AS COMPONENTS OF LIQUID CRYSTAL PHASES MERCK PATENT GMBH (DE) 1995-02-08 EP disclosed
US-4913837-A Heterocyclic compounds MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1990-04-03 US disclosed
WO-1987004158-A2 HETEROCYCLIC COMPOUNDS AS COMPONENTS OF LIQUID CRYSTAL PHASES MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 1987-07-16 WO disclosed
US-4676924-A Liquid crystalline isothiocyanates with dioxane ring and liquid crystalline admixtures containing same WOJSKOWA AKADEMIA TECHNICZNA (PL) 1987-06-30 US disclosed
EP-0170082-A2 Liquid crystalline isothiocyanates with a dioxane ring and liquid crystalline admixtures containing the same Wojskowa Akademia Techniczna im. Jaroslawa Dabrowskiego (PL) 1986-02-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160068483-A1 AMIDE DERIVATIVES OF LACTAM BASED N-ACYLETHANOLAMINE ACID AMIDASE (NAAA) INHIBITORS NAAA, FAAH, FAAH2 ALDH1A1 1090/4885HPGD 567/4885HSD17B10 674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.